Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Samuels

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B studyB L Samuels, D R Hollis, G L Rosner, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Modulation of vinblastine resistance with cyclosporine: a phase I studyB L Samuels, R Mick, N J Vogelzang, et al.
Cancer|April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group BB L Samuels, J E Herndon, D C Harmon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2013
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program studyB L Samuels, S Chawla, S Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancerG A Masters, A M Mauer, P C Hoffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancerG A Masters, P C Hoffman, A Hsieh, et al.
Cancer Research|January 15, 1991
Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistanceB L Samuels, J L Murray, M B Cohen, et al.
The Cancer Journal From Scientific American|November 1, 1995
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancerG A Masters, L C Drinkard, P C Hoffman, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancerP C Hoffman, S A Krauss, L C Drinkard, et al.
Seminars in Oncology|October 1, 1994
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study designE E Vokes, L C Drinkard, B L Samuels, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B studyB L Samuels, D R Hollis, G L Rosner, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Modulation of vinblastine resistance with cyclosporine: a phase I studyB L Samuels, R Mick, N J Vogelzang, et al.
Cancer|April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group BB L Samuels, J E Herndon, D C Harmon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2013
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program studyB L Samuels, S Chawla, S Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancerG A Masters, A M Mauer, P C Hoffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancerG A Masters, P C Hoffman, A Hsieh, et al.
Cancer Research|January 15, 1991
Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistanceB L Samuels, J L Murray, M B Cohen, et al.
The Cancer Journal From Scientific American|November 1, 1995
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancerG A Masters, L C Drinkard, P C Hoffman, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancerP C Hoffman, S A Krauss, L C Drinkard, et al.
Seminars in Oncology|October 1, 1994
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study designE E Vokes, L C Drinkard, B L Samuels, et al.
Pageof 5